| Literature DB >> 32705715 |
Min Shen1,2, Minmin Tu1, Wei Zhang1, Jihua Zou1, Man Zhang2, Zheng Cao3, Bingde Zou1.
Abstract
BACKGROUND: We developed an ion chromatography (IC) method for measurement of chloride in human serum which was regarded as a simple, rapid, accurate, and sensitive technique. The method will be hopefully selected as a candidate reference method.Entities:
Keywords: candidate reference method; ion chromatography; serum chloride
Mesh:
Substances:
Year: 2020 PMID: 32705715 PMCID: PMC7439436 DOI: 10.1002/jcla.23296
Source DB: PubMed Journal: J Clin Lab Anal ISSN: 0887-8013 Impact factor: 2.352
Figure 1Serum chromatogram after dilution
Figure 2The standard curve of chloride
Linear range, the limit of detection, and the limit of quantitation of chloride
| Program | Linear range (mmol/L) | Regression equation | Correlation coefficient | LOD (mmol/L) | LOQ (mmol/L) |
|---|---|---|---|---|---|
| Cl | 0‐0.42 |
|
| 9.87 × 10−5 | 3.29 × 10−4 |
Abbreviations: LOD, low limit of detection; LOQ, low limit of quantification.
Precision of Ion chromatography analysis of chloride in serum
| Concentration level | Mean (mmol/L) | Within‐run CVs (%) | Mean (mmol/L) | Between‐run CVs (%) |
|---|---|---|---|---|
| Low | 90.46 | 0.32 | 90.70 | 0.58 |
| Medium | 108.05 | 0.73 | 108.86 | 0.97 |
| High | 127.37 | 0.50 | 128.39 | 0.96 |
Comparison of values between serum samples and SRM 956d
| Name | Measured value (mmol/L) | CV (%) | Standard value (mmol/L) | Bias (%) | IFCC Equivalent limit |
|---|---|---|---|---|---|
| NIST SRM 956d L1 | 93.98 | 0.79 | 94.53 ± 0.21 | −0.58 | ±2.00% |
| NIST SRM 956d L2 | 107.55 | 0.28 | 108.5 ± 0.2 | −0.88 | |
| NIST SRM 956d L3 | 121.56 | 0.43 | 122.6 ± 0.3 | −0.85 |
Comparison of values between serum samples and IFCC External Quality assessment scheme for Reference Laboratories in Laboratory Medicine (IFCC‐RELA) samples
| Name | Measured value (mmol/L) | CV (%) | Extended uncertainty (mmol/L) | Target value (mmol/L) | Bias (%) | IFCC equivalent limit |
|---|---|---|---|---|---|---|
| 2013RELA‐A | 110.66 | 0.44 | 0.83 | 109.88 | 0.71 | ±2.00% |
| 2013RELA‐B | 113.76 | 0.81 | 0.77 | 112.98 | 0.70 | |
| 2014RELA‐A | 120.35 | 0.42 | 0.75 | 119.80 | 0.46 | |
| 2014RELA‐B | 125.62 | 0.59 | 0.91 | 124.88 | 0.59 | |
| 2015RELA‐A | 125.40 | 0.67 | 0.64 | 124.30 | 0.88 | |
| 2015RELA‐B | 129.60 | 0.42 | 0.73 | 128.15 | 1.13 | |
| 2016RELA‐A | 118.57 | 0.37 | 1.10 | 118.03 | 0.49 | |
| 2016RELA‐B | 138.40 | 0.80 | 0.61 | 137.43 | 0.71 | |
| 2017RELA‐A | 127.40 | 0.70 | 1.30 | 127.46 | −0.05 | |
| 2017RELA‐B | 122.80 | 0.81 | 1.30 | 123.11 | −0.25 | |
| 2018RELA‐A | 118.15 | 0.72 | 0.93 | 118.16 | −0.55 | |
| 2018RELA‐B | 143.76 | 0.43 | 0.93 | 144.60 | −0.55 |
Figure 3The comparison of ICP‐MS and IC